Researchers behind Replimune’s melanoma study offer a rare protest of FDA’s CRLnews2025-08-04T17:19:03+00:00August 4th, 2025|Endpoints News|
Hansa says small trial shows its investigational drug could expand use of Sarepta’s Elevidysnews2025-08-04T11:29:29+00:00August 4th, 2025|Endpoints News|
Regeneron CEO speaks on Trump’s ‘most favored nation’ pricingnews2025-08-01T15:29:13+00:00August 1st, 2025|Endpoints News|
Analysts wary of Moderna’s CMV fate after new endpoints addednews2025-08-01T15:14:55+00:00August 1st, 2025|Endpoints News|
Allogene says lymphodepletion drug caused patient death, changes CAR-T study designnews2025-08-01T12:30:30+00:00August 1st, 2025|Endpoints News|
4DMT’s eye gene therapy cuts need for injections that treat diabetic macular edemanews2025-07-31T20:41:21+00:00July 31st, 2025|Endpoints News|
ImmuneOnco, Instil Bio’s PD-L1xVEGF posts encouraging mid-stage datanews2025-07-31T14:42:44+00:00July 31st, 2025|Endpoints News|
Endpoints livestream: Is China’s biotech boom unstoppable?news2025-07-31T14:33:56+00:00July 31st, 2025|Endpoints News|
Radella hopes muscle-sparing obesity approach will make it stand outnews2025-07-31T12:00:16+00:00July 31st, 2025|Endpoints News|
Lilly’s Mounjaro succeeds in cardiovascular outcomes trial, heads for expanded approvalnews2025-07-31T10:45:44+00:00July 31st, 2025|Endpoints News|
